Literature DB >> 27324993

A Mathematical Model of Granulopoiesis Incorporating the Negative Feedback Dynamics and Kinetics of G-CSF/Neutrophil Binding and Internalization.

M Craig1,2, A R Humphries3, M C Mackey4.   

Abstract

We develop a physiological model of granulopoiesis which includes explicit modelling of the kinetics of the cytokine granulocyte colony-stimulating factor (G-CSF) incorporating both the freely circulating concentration and the concentration of the cytokine bound to mature neutrophils. G-CSF concentrations are used to directly regulate neutrophil production, with the rate of differentiation of stem cells to neutrophil precursors, the effective proliferation rate in mitosis, the maturation time, and the release rate from the mature marrow reservoir into circulation all dependent on the level of G-CSF in the system. The dependence of the maturation time on the cytokine concentration introduces a state-dependent delay into our differential equation model, and we show how this is derived from an age-structured partial differential equation model of the mitosis and maturation and also detail the derivation of the rest of our model. The model and its estimated parameters are shown to successfully predict the neutrophil and G-CSF responses to a variety of treatment scenarios, including the combined administration of chemotherapy and exogenous G-CSF. This concomitant treatment was reproduced without any additional fitting to characterize drug-drug interactions.

Entities:  

Keywords:  Bound and unbound drug concentrations; G-CSF; Granulopoiesis; Mathematical modelling; Physiologically constructed pharmacokinetics; State-dependent delay differential equations

Mesh:

Substances:

Year:  2016        PMID: 27324993     DOI: 10.1007/s11538-016-0179-8

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   1.758


  17 in total

1.  A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitor.

Authors:  Wenbo Chen; Britton Boras; Tae Sung; Yanke Yu; Jenny Zheng; Diane Wang; Wenyue Hu; Mary E Spilker; David Z D'Argenio
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-03-11       Impact factor: 2.745

2.  Normal and pathological dynamics of platelets in humans.

Authors:  Gabriel P Langlois; Morgan Craig; Antony R Humphries; Michael C Mackey; Joseph M Mahaffy; Jacques Bélair; Thibault Moulin; Sean R Sinclair; Liangliang Wang
Journal:  J Math Biol       Date:  2017-04-08       Impact factor: 2.259

3.  An upper bound for the half-removal time of neutrophils from circulation.

Authors:  Morgan Craig; Antony R Humphries; Michael C Mackey
Journal:  Blood       Date:  2016-08-30       Impact factor: 22.113

4.  Transit and lifespan in neutrophil production: implications for drug intervention.

Authors:  Daniel Câmara De Souza; Morgan Craig; Tyler Cassidy; Jun Li; Fahima Nekka; Jacques Bélair; Antony R Humphries
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-12-13       Impact factor: 2.745

5.  Response of an oscillatory differential delay equation to a periodic stimulus.

Authors:  Daniel C De Souza; Michael C Mackey
Journal:  J Math Biol       Date:  2019-01-12       Impact factor: 2.259

6.  Predicting Time to Relapse in Acute Myeloid Leukemia through Stochastic Modeling of Minimal Residual Disease Based on Clonality Data.

Authors:  Khanh N Dinh; Roman Jaksik; Seth J Corey; Marek Kimmel
Journal:  Comput Syst Oncol       Date:  2021-09-14

7.  Effects of Prophylactic Administration of Granulocyte Colony-Stimulating Factor on Peripheral Leukocyte and Neutrophil Counts Levels After Chemotherapy in Patients With Early-Stage Breast Cancer: A Retrospective Cohort Study.

Authors:  Wei Tian; Yali Wang; Yunxiang Zhou; Yihan Yao; Yongchuan Deng
Journal:  Front Oncol       Date:  2022-04-25       Impact factor: 5.738

8.  Optimal experimental design for mathematical models of haematopoiesis.

Authors:  Luis Martinez Lomeli; Abdon Iniguez; Prasanthi Tata; Nilamani Jena; Zhong-Ying Liu; Richard Van Etten; Arthur D Lander; Babak Shahbaba; John S Lowengrub; Vladimir N Minin
Journal:  J R Soc Interface       Date:  2021-01-27       Impact factor: 4.118

Review 9.  Systems Modeling to Quantify Safety Risks in Early Drug Development: Using Bifurcation Analysis and Agent-Based Modeling as Examples.

Authors:  Carmen Pin; Teresa Collins; Megan Gibbs; Holly Kimko
Journal:  AAPS J       Date:  2021-05-20       Impact factor: 4.009

10.  Mechanistic models for hematological toxicities: Small is beautiful.

Authors:  Laure Deyme; Sébastien Benzekry; Joseph Ciccolini
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.